Jan Mueller-Berghaus M.D. is paediatrician by training and joined the Paul-Ehrlich-Institut as clinical expert in 2005. The Paul-Ehrlich-Institut is the German Federal Agency for Vaccines and Biomedicines and is actively participating in all aspects of German and European marketing authorisation as well as clinical trial authorisation. He is currently the German member of the Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA) and in 2017 he was re-elected as co-opted member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.
Monday, September 14, 2020
10:00 AM – 11:30 AM EDT